Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Change in Intangibles (2023 - 2025)

Historic Change in Intangibles for Mereo BioPharma (MREO) over the last 3 years, with Q1 2025 value amounting to $300000.0.

  • Mereo BioPharma's Change in Intangibles fell 5714.29% to $300000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $300000.0, marking a year-over-year decrease of 5708.15%. This contributed to the annual value of $699000.0 for FY2024, which is 6682.58% up from last year.
  • As of Q1 2025, Mereo BioPharma's Change in Intangibles stood at $300000.0, which was down 5714.29% from -$1000.0 recorded in Q2 2024.
  • In the past 5 years, Mereo BioPharma's Change in Intangibles ranged from a high of $700000.0 in Q1 2024 and a low of -$1000.0 during Q2 2024
  • Moreover, its 3-year median value for Change in Intangibles was $359500.0 (2023), whereas its average is $354500.0.
  • Its Change in Intangibles has fluctuated over the past 5 years, first skyrocketed by 6706.44% in 2024, then plummeted by 5714.29% in 2025.
  • Over the past 3 years, Mereo BioPharma's Change in Intangibles (Quarter) stood at $419000.0 in 2023, then crashed by 100.24% to -$1000.0 in 2024, then surged by 30100.0% to $300000.0 in 2025.
  • Its Change in Intangibles was $300000.0 in Q1 2025, compared to -$1000.0 in Q2 2024 and $700000.0 in Q1 2024.